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Abstract 
 
Background: Exposure of children to environmental tobacco smoke at 
home has been linked to many complications including respiratory 
symptoms, airway inflammation and impaired lung ventilatory functions; 
however, factors like housing conditions and genetic predisposition may 
influence the development of these complications.   
Objectives: To determine the effects of passive smoking on spirometric 
values and plasma level of inflammatory markers in healthy male school-
children. 
Methods: This is an observational case control study conducted in year 
2009 among 135 male school-pupils (69 cases and 66 controls), aged 9-14 
(mean 11.6 ± 1.3) years, selected randomly from three governmental 
primary schools for boys in Khartoum. Information about smoking history, 
its impact on child’s health and the attitude of parents towards passive 
smoking was collected from each pupil and his parents using a 
questionnaire. Spirometric measurements were performed using Clement 
Clarke All-flow Spirometer. Plasma CRP, IL4 and TNFα were measured 
using ELISA kits. 
Results: Fathers were responsible for 67.5% of second-hand smoke at 
home; mothers were responsible for 2.5% whereas relatives like brothers 
and uncles were responsible for 30%. The group of cases showed a 
significant rise in plasma TNFα and IL4 and a significant reduction in FVC 
and FEV1 by about (7-8%). The rise in plasma TNFα and IL4 was higher in 
those with high degree of tobacco smoke exposure than those with low 
exposure, indicating a dose dependent effect. No significant difference was 
V 
 
found in frequencies of hospital admissions, surgical operations and 
respiratory tract infections during the last year; however, snoring during 
sleep was significantly higher among cases (8.2%) than controls (2.2%). 
The majority of fathers in the study group did not smoke or allow smoking 
near their wives during pregnancy (90%).   
Conclusion & recommendation: Passive smoking has a significant 
negative impact on lung function of healthy male school-pupils in 
Khartoum and a significant dose dependent effect on plasma TNFα and 
IL4.Educational programs are highly recommended to increase awareness 
of parents about the negative impact of passive smoking on child’s health. 
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 ﻣﻠﺨﺺ اﻻﻃﺮوﺣﺔ
 
ﻃﻔﺎل ﻟﺪﺧﺎن اﻟﺘﺒﻎ اﻟﺒﻴﺌﻲ ﻓﻲ اﻟﻤﻨﺰل ﺑﺎﻟﻜﺜﻴﺮ ﻣﻦ اﻟﻤﻀﺎﻋﻔﺎت اﻟﺘﻲ ﺗﻌﺮض اﻷ ﻗﺪ ﺗﻢ رﺑﻂ: اﻟﺨﻠﻔﻴﺔ 
ﻋﻮاﻣﻞ ﻣﺜﻞ ﻟﻜﻦ اﻟﺮﺋﺔ و ﻳﺔﺗﻬﻮ ﺗﺘﻀﻤﻦ أﻋﺮاض ﺗﻨﻔﺴﻴﺔ ، اﻟﺘﻬﺎب اﻟﺸﻌﺐ اﻟﻬﻮاﺋﻴﺔ وﺿﻌﻒ وﻇﺎﺋﻒ
  .ﺛﺮ ﻋﻠﻰ ﺗﻄﻮر هﺬﻩ اﻟﻤﻀﺎﻋﻔﺎتﺆﺗﻗﺪ ﻇﺮوف اﻟﺴﻜﻦ واﻻﺳﺘﻌﺪاد اﻟﻮراﺛﻲ 
ﻟﺘﻬﺎب ﻣﻘﻴﺎس اﻟﺘﻨﻔﺲ وﻣﺴﺘﻮي ﻣﺆﺷﺮات اﻻﻣﻌﺎﻳﻴﺮ ﻟﺘﺤﺪﻳﺪ ﺗﺄﺛﻴﺮ اﻟﺘﺪﺧﻴﻦ اﻟﺴﻠﺒﻲ ﻋﻠﻰ ﻗﻴﻢ  :اﻷهﺪاف 
  .اﻟﺬآﻮر اﻟﻤﺪارس اﻷﺻﺤﺎء أﻃﻔﺎلﺑﻼزﻣﺎ  ﻓﻲ
 ﺗﻠﻤﻴﺬ ﻣﺪرﺳﺔ 531 ﻓﻲ 9002أﺟﺮﻳﺖ ﻓﻲ ﻋﺎم ،  ﺿﺎﺑﻂ ﺣﺎﻟﺔ ، ﻣﺮاﻗﺒﺔﻩ دراﺳﺔ هﺬ :اﻷﺳﺎﻟﻴﺐ 
ﺳﻨﻮات ، ﺗﻢ ( 3.1 ± 6.11اﻟﻤﺘﻮﺳﻂ ) 41-9 ، ﺗﺘﺮاوح أﻋﻤﺎرهﻢ ﺑﻴﻦ ( ﺿﺎﺑﻂ 66ﺣﺎﻟﺔ و  96)
ﻤﻌﻠﻮﻣﺎت ﻋﻦ ﺗﺎرﻳﺦ اﻟ. اﺑﺘﺪاﺋﻴﺔ ﻟﻠﺒﻨﻴﻦ ﻓﻲ اﻟﺨﺮﻃﻮمﺣﻜﻮﻣﻴﺔ ث ﻣﺪارس ﻋﺸﻮاﺋﻴﺎ ﻣﻦ ﺛﻼ ﻢاﺧﺘﻴﺎره
ﺘﻠﻤﻴﺬ اﻟﺘﺪﺧﻴﻦ وﺗﺄﺛﻴﺮﻩ ﻋﻠﻰ ﺻﺤﺔ اﻟﻄﻔﻞ وﻣﻮﻗﻒ اﻵﺑﺎء ﺗﺠﺎﻩ اﻟﺘﺪﺧﻴﻦ اﻟﺴﻠﺒﻲ ﺗﻢ ﺟﻤﻌﻬﺎ ﻣﻦ آﻞ ﻣﻦ اﻟ
آﻠﻴﻤﻨﺖ ﻣﻘﻴﺎس ﺗﻨﻔﺲ ﻣﻦ  أﺟﺮﻳﺖ ﺑﺎﺳﺘﺨﺪامﻗﻴﻢ ﻣﻌﺎﻳﻴﺮ اﻟﺘﻨﻔﺲ ﻗﻴﺎﺳﺎت . وﻋﺎﺋﻠﺘﻪ ﺑﺎﺳﺘﺨﺪام اﺳﺘﺒﻴﺎن
  .ﺑﺎﺳﺘﺨﺪام ﻣﺠﻤﻮﻋﺎت اﻻﻟﻴﺰا ﻓﻲ اﻟﺒﻼزﻣﺎ PRC  و FNT و 4LI ﺗﻢ ﻗﻴﺎس  .آﻼرك
 آﻦ؛ اﻷﻣﻬﺎت  اﻟﻤﻨﺰل٪ ﻣﻦ دﺧﺎن اﻟﺘﺒﻎ ﻏﻴﺮ اﻟﻤﺒﺎﺷﺮ ﻓﻲ  76ﻋﻦ  ﻴﻦﻣﺴﺆوﻟﻮا اﻵﺑﺎء آﺎﻧ :اﻟﻨﺘﺎﺋﺞ 
ﻴﻦ  ﻋﻦ ﺣﻮاﻟﻲ ﻣﺴﺆوﻟﻮا ﻗﺎرب ﻣﺜﻞ اﻻﺧﻮة واﻷﻋﻤﺎم آﺎﻧاﻷ٪ ﻓﻲ ﺣﻴﻦ أن  2ﻋﻦ ﺣﻮاﻟﻲ  تﻣﺴﺆوﻻ
و اﻧﺨﻔﺎض ﻣﻠﺤﻮظ ﻓﻲ         4LIو  αFNTﻓﻲ ﻣﻠﺤﻮظ ارﺗﻔﺎع ﻋﻦ آﺸﻔﺖ  ﻣﺠﻤﻮﻋﺔ اﻟﺤﺎﻻت .  ٪ 03
اﻟﺒﻼزﻣﺎ آﺎن أﻋﻠﻲ ﻓﻲ اﻟﺬﻳﻦ  4LIو  αFNTرﺗﻔﺎع ﻓﻲ اﻻ %. 8- 7ﺑﺤﻮاﻟﻲ    1VEF(،CVF) 
ﻣﻦ اﻟﺬﻳﻦ ﺗﻌﺮﺿﻮا ﻟﺪرﺟﺔ ﻣﻨﺨﻔﻀﺔ ، ﻣﻤﺎ ﻳﺸﻴﺮ اﻟﻲ ﺗﺄﺛﻴﺮ  دﺧﺎن اﻟﺘﺒﻎﺗﻌﺮﺿﻮا ﻟﺪرﺟﺔ ﻋﺎﻟﻴﺔ ﻣﻦ 
ﻻ ﻳﻮﺟﺪ ﻓﺮق آﺒﻴﺮ ﻓﻲ ﺗﻮاﺗﺮ ﺣﺎﻻت دﺧﻮل اﻟﻤﺴﺘﺸﻔﻴﺎت واﻟﻌﻤﻠﻴﺎت اﻟﺠﺮاﺣﻴﺔ  .ﻳﻌﺘﻤﺪ ﻋﻠﻲ اﻟﺠﺮﻋﺔ
واﻟﺘﻬﺎﺑﺎت اﻟﺠﻬﺎز اﻟﺘﻨﻔﺴﻲ ﺧﻼل اﻟﻌﺎم اﻟﻤﺎﺿﻲ ، إﻻ أن اﻟﺸﺨﻴﺮ أﺛﻨﺎء اﻟﻨﻮم آﺎن ﻣﺮﺗﻔﻌﺎ ﺑﺸﻜﻞ آﺒﻴﺮ 
ﻏﺎﻟﺒﻴﺔ اﻵﺑﺎء ﻓﻲ آﻞ ﻣﺠﻤﻮﻋﺔ اﻟﺪراﺳﺔ ﻻ (. ٪ 2.2)ﺎﻟﻀﻮاﺑﻂ ﻘﺎرﻧﺔ ﺑﻣ( ٪ 2.8)ﺤﺎﻻت اﻟﺑﻴﻦ 
  (. ٪ 09)ﻦ ﻗﺮب زوﺟﺎﺗﻬﻢ ﺧﻼل ﻓﺘﺮة اﻟﺤﻤﻞ ﺑﺎﻟﺘﺪﺧﻴ ﻮنﻳﺴﻤﺤ
اﻟﺒﻼزﻣﺎ  ﻣﺆﺷﺮات اﻻﻟﺘﻬﺎب ﻓﻲ ﻋﻠﻰ ﻣﺴﺘﻮى ﻣﻘﺪراﻟﺘﺪﺧﻴﻦ اﻟﺴﻠﺒﻲ ﻟﻪ ﺗﺄﺛﻴﺮ  :ﺘﻮﺻﻴﺔ واﻟ اﻻﺳﺘﻨﺘﺎج
  . ﻓﻲ اﻟﺨﺮﻃﻮم اﻟﺬآﻮر رسااﻟﻤﺪﺗﻼﻣﻴﺬ ﻓﻲ ﻣﻌﺎﻳﻴﺮ ﻣﻘﻴﺎس اﻟﺘﻨﻔﺲ ارﺗﺒﺎط ﺿﻌﻴﻒ ﻣﻊ ﻗﻴﻢ وﻟﻪ 
ﻟﻠﺘﺪﺧﻴﻦ اﻟﺴﻠﺒﻲ ﻋﻠﻰ ﺻﺤﺔ ﻀﺎراﻟﺘﺄﺛﻴﺮ اﻟ ﻟﺰﻳﺎدة اﻟﻮﻋﻲ ﺣﻮلﻣﻮﺻﻲ ﺑﻬﺎ ﺑﻘﻮة  اﻟﺒﺮاﻣﺞ اﻟﺘﻌﻠﻴﻤﻴﺔ
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CHAPTER ONE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2
1. INTRODUCTION & LITERATURE REVIEW 
1.1 Cigarette smoking 
1.1.1. History 
Smoking was probably first practiced by the indigenous people of the 
Western Hemisphere. Originally used in religious and social rituals and in 
some instances for medical purposes.(1,2) By the time Europeans arrived 
on the American continent in the fifteenth century, smoking of tobacco was 
popular among the natives. Christopher Columbus and his sailors were 
given tobacco, among other gifts, by the American Indians in 1492. Then 
tobacco leaves and seeds were brought back with them to Europe for the 
first time.(1) By the end of the sixteenth century, smoking of tobacco had 
became a widespread practice.(1,2) However, many rules prohibited its use 
and penalized offenders. Near the end of the nineteenth century, mass 
production of cigarettes had begun. Following this, smoking of cigarettes 
gradually became prevalent as the use of cigars and pipes declined.(1-3) 
 
During the early stages of the smoking epidemic, and before the mass 
production of cigarettes, women were not regarded as smokers in public 
although some of them did smoke in private.(4) In the 1920s, the tobacco 
companies began to attract women as smokers through media and cigarette 
advertising. This contributed to a culture in which smoking was normalized 
and had a positive image. Since that time the behavior of women was 
changed and female smoking started to rise.(4) 
 
In the Sudan, nobody knows exactly where and how tobacco was 
introduced, but the archeological excavations in the Northern part of the 
country discovered the use of tobacco pipes dating back to Christian era 
(6th-14th century A.D.).(5) The earliest recorded information is very recent; 
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early nineteenth century by the Turks. Scattered small areas were grown 
with varieties of tobacco for domestic consumption. Later during the 
Mahdi's rule, the use of tobacco in all its forms was considered a sin and 
thus prohibited. In the twentieth century, smoking of imported and locally 
manufactured cigarettes became increasingly popular among many 
Sudanese subjects.(5) 
 
 
1.1.2 Prevalence 
Despite increasing information about the adverse effects of smoking and 
bans on smoking by some governments, the use of tobacco continued to 
increase.(6) The third edition of the “Tobacco Atlas”, published by the 
World Lung Foundation and the American Cancer Society, was launched in 
March 2009 during the 14th World Conference on Tobacco or Health in 
Mumbai, India. According to the atlas, more than one billion men and 
about 250 million women use tobacco every day.(7) The atlas states that, 
by 2010, tobacco will be killing 6 million people worldwide each year, and 
72% of these deaths will be in low and middle-income countries. These 
countries are of particular focus for the tobacco companies because they 
have ineffective health policies and fewer resources to curb smoking.(7) It 
was estimated that since 1960 tobacco production has increased 300% in 
the developing countries while dropping more than 50% in the developed 
countries”.(7) A 1988 WHO press release reported that while tobacco 
markets are decreasing in Western, industrialized countries at the rate of 
1% per year, tobacco consumption is increasing in the developing countries 
at an average rate of 2% per year.(8) 
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In the Sudan, there is paucity of data regarding the prevalence of smoking 
among Sudanese subjects. In their cross sectional study in 1998 in the Nile 
State, Idris et al. found that 12% of adult males and 0.9% of adult females 
are cigarette smokers.(9) According to the study the prevalence of cigarette 
smoking is significantly higher in the urban areas whereas toombak use is 
higher in the rural areas.  
 
In the past, the number of smokers rose as incomes increased within 
populations.(10) Smokers in high-income countries were more likely to be 
affluent than poor. This pattern appears to have reversed among men in the 
past few decades when affluent men have increasingly quit smoking, 
whereas poorer men have not.(10) A similar inverse relationship is found 
between educational levels and smoking. In general, individuals who have 
received little or no education are more likely to smoke than those who are 
more educated.(10) These two inverse relationships are unlikely to exist in 
the developing countries like the Sudan. A survey in Khartoum showed that 
64% of doctors and university lecturers, and 34% of medical students, were 
smokers.(11) Similar results were obtained in other parts of the developing 
world.(12)  
 
The 1998 prevalence of cigarette smoking among children and adolescents 
in the Nile State was quite low (about 2%).(9) Later in 2001, the Sudan 
Global Youth Tobacco Survey, a national school-based survey of pupils in 
8th primary grade “1st secondary grade and 2nd secondary grade” estimated 
that the use of all tobacco products by pupils was 20.3% in males and 
12.9% in female.(13) In 2005, the survey was conducted again and the 
prevalence among school pupils of the same age group was 29.4% and 
13.3% in males and females respectively.(14) 
 5
1.1.3 Contents of tobacco smoke 
Tobacco smoke contains over 4000 chemicals in the form of particulates 
and gases.(15-19) The particulate phase (5% by weight) includes tar (itself 
composed of many chemicals), nicotine, benzene and benzo(a)pyrene. The 
gas phase (95% by weight) includes carbon monoxide, ammonia, 
dimethylnitrosamine, formaldehyde, hydrogen cyanide and acrolein. All 
these substances are emitted from a burning cigarette.(15-19) Some of 
these have marked irritant properties and some are known or suspected 
carcinogens. Tobacco smoke is classified as a class "A" carcinogen along 
with asbestos, arsenic, benzene and radon gas.(18,19) 
 
 
1.1.4 Health hazards 
As early as the eighteenth century, a number of physicians had observed a 
relation between the use of tobacco and lung disease. However, the relation 
to lung cancer remained largely debatable.(3) Around the middle of the 
twentieth century, several case control studies of lung cancer etiology were 
published in Europe and North America.(20-22) This led to a conclusion in 
1950 that cigarette smoking is an important cause of lung cancer.(23) Since 
then, knowledge about the adverse health effects of smoking has 
accumulated. In 1964 a definitive proof that cigarette smoking was a 
serious health hazard was contained in a report by the Surgeon General’s 
Advisory Committee on Health, appointed by the Public Health Service of 
the United States.(24) The committee drew evidence from numerous 
studies conducted over decades. They concluded that a smoker had a 
significantly greater chance of contracting lung cancer than a nonsmoker. 
The rate varied according to factors such as the number of cigarettes 
smoked per day, the number of years the subject smoked and the time in 
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the person’s life when he or she began smoking.(24) Cigarette smoking 
was also found to be associated with cancers of the mouth, esophagus, 
nasopharynx, larynx, kidney, and urinary bladder,(25-28) as well as a cause 
of chronic obstructive pulmonary disease, impaired lung function, heart 
disease, stroke, and many other cardiovascular, pulmonary and 
neurological diseases.(29-34) In addition, it was an independent risk factor 
in male impotence.(35) On average, it was calculated that someone who 
smokes a pack or more of cigarettes each day lives 7 years less than 
someone who never smoked.(36)  
 
 
1.2 Passive cigarette smoking 
1.2.1 Background 
Breathing other people's smoke is called passive, involuntary, 
environmental or secondhand smoking.(7) The environmental tobacco 
smoke is a major source of indoor air pollution. The non-smoker breathes 
"side-stream" smoke from the burning tip of the cigarette and "main-
stream" smoke that has been inhaled and then exhaled by the smoker. 
Nearly 85% of the smoke in a room results from side-stream smoke and it 
is worth noting that many potentially toxic gases are present in higher 
concentrations in side-stream smoke than in main-stream smoke.(16,17) 
 
 
1.2.2 Prevalence 
The percentage of passive smokers in a population is far higher than that of 
active smokers. For example in the United States, where active smokers 
comprise approximately 26% of the adult population,(37) tobacco exposure 
is confirmed in more than 80% of non-smokers.(38) A bout 37% of adults 
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and 43% of children 2 months to 11 years of age live in homes with at least 
one smoker.(38) In the United Kingdom, almost half of all children are 
exposed to tobacco smoke at home.(39) It was estimated that almost half of 
the world’s children were passive smokers.(7) In the Sudan, 28.4% of 
school pupils live in homes where others smoke in their presence and 
16.5% of all pupils have one or more parents who smoke.(13) 
 
 
1.2.3 Health hazards in adults  
Evidence of the health impact of passive smoking has been building up 
over the past decades. The first conclusive evidence on the dangers of 
passive smoking is supposed to came from Takeshi Hirayama's study in 
1981 on prevalence of lung cancer in non smoking Japanese women 
married to heavy smoker men.(40) Wives of heavy smokers were found to 
have a higher risk of developing lung cancer than wives of non-smokers. 
Since then, environmental tobacco smoke is increasingly recognized as a 
direct cause of disease in adults and children.  
 
Some of the immediate effects of passive smoking include eye irritation, 
headache, cough, sore throat, dizziness and nausea.(41) Adults with asthma 
can experience a significant decline in lung functions when exposed to 
environmental tobacco smoke and increased bronchial reactivity.(42,43) 
However, significant increase in bronchial reactivity is not confirmed in 
Sudanese adults when exposed to environmental tobacco smoke before 
exercise.(44) In addition, short-term exposure has a measurable effect on 
the heart in non-smokers. Just 30 minutes exposure is enough to cause 
significant reduction in the coronary flow velocity reserve.(45)  
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In the longer term, passive smokers suffer an increased risk of a range of 
smoking-related diseases, including increased risk of respiratory disease, 
ischemic heart disease and lung cancer.(46-50) The 1992 United States 
Environmental Protection Agency review on passive smoking included 
reports on a relationship between environmental tobacco smoke, respiratory 
symptoms and sickness in adults.(51) Workplace exposure is more strongly 
related to respiratory symptoms than household exposure.(52-54) Studies 
conducted in some developed countries in the early 1990s estimated that 
heart disease caused by passive smoking was the third leading preventable 
cause of death, ranking behind active smoking and alcohol abuse, and that 
non-smokers living with smokers had an increased risk of heart disease of 
around 30%.(55-56) Another study in the United States showed an elevated 
risk of heart disease among passive smokers of around 20%.(57) In 
addition, Whincup et al.  suggested that previous studies of the effects of 
passive smoking on the risk of heart disease might have been under-
estimated. They found that blood cotinine levels, a biomarker of nicotine 
breakdown in the liver, among non-smokers were associated with a 50-60% 
increased risk of heart disease.(58) However, cotinine may not be specific 
for environmental tobacco exposure because dietary nicotine (eg, green 
pepper, tomato and tea) may elevate cotinine levels. 
 
 
1.2.4 Health hazards in children: 
Because many young children spend a large proportion of their time 
indoors, they may have significant exposure to environmental tobacco 
smoke at home.(59) This passive smoking has harmful effects on the 
respiratory health of such children.(60,61) Many studies have documented 
an increased incidence of lower respiratory tract infections in children 
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exposed to environmental tobacco smoke compared to those without 
exposure.(62-64) Infants whose parents smoke are more likely to have 
pneumonia and bronchitis than infants whose parents do not smoke.(65) 
Children with asthma whose parents smoke have more frequent 
exacerbations and more severe symptoms.(66-68) In an interventional 
study, it was demonstrated that if parents expose their children with asthma 
to less cigarette smoke, the asthmatic symptoms will be less severe.(69)  
 
Middle ear problems that need surgical treatment are more likely to occur 
in children who live in households where more than three packs of 
cigarettes are smoked per day.(70) Middle ear effusion is about 60% more 
likely to develop in children whose parents smoke.(71) Moreover, a 
growing body of evidence links environmental tobacco smoke exposure to 
sudden infant death syndrome.(72-78) This relationship seems to be 
independent of birth weight and gestational age. Passive smoking has also 
been reported to alter lipid profiles in adolescents.(79) This may shed light 
on the mechanism of increased risk of coronary heart disease in passive 
smokers.  
 
A number of studies have examined the relationship between passive 
smoking during childhood and the risk of cancer.(80-83) Some studies 
found some support for the hypothesis that paternal cigarette smoking is a 
potential risk factor for the generation of childhood cancers.(83) Exposure 
to tobacco smoke may also impair olfactory function in children. A 
Canadian study found that passive smoking reduced children’s ability to 
detect a wide variety of odors compared with children raised in non-smoking 
households.(84) Passive smoking may also affect children’s mental 
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development. A study conducted in USA found deficits in reading and 
reasoning skills among children even at low levels of smoke exposure.(85)  
 
 
1.2.5 The adverse effects on pulmonary function tests in children  
1.2.5.1 Pulmonary function tests  
Pulmonary function tests are important tools for diagnosis and follow up of 
many respiratory problems. Abnormalities may appear even if the patient is 
asymptomatic. The tests assess the ventilatory functions of the lung 
(spirometry), airway resistance, gas diffusion, elastic properties of the lung, 
ventilation perfusion relationship and blood gases.(85)  
 
Spirometry is the most commonly used test in assessment of lung 
ventilation. It detects presence of airflow obstruction or lung restriction, 
evaluates severity of obstruction or restriction, aids in the differential 
diagnosis of respiratory illness, assesses disease progression and evaluates 
response to treatment.(86) Spirometers are designed to measure changes in 
volume and when they are equipped with electronic signal outputs 
(pneumotachs), they also measure flow (volume per unit of time). The flow 
volume and volume time curves, as well as the absolute values for flows 
and volumes, should be considered during interpretation of spirometric 
results.  
 
The parameters measured by spirometers include the following: 
i- Forced vital capacity (FVC), the volume of air expired forcefully by 
full expiratory effort following maximum inspiration. 
ii- Forced expiratory volume in the first second (FEV1), the volume of 
air expired in the first second of the FVC. 
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iii-  FEV1/FVC ratio (FEV1/FVC%), the ratio of FEV1 to FVC.  
iv-  The forced expiratory flow 25% (FEF25%), the amount of air that is 
forcibly expelled during the first 25% of the total forced vital 
capacity. 
v- The forced expiratory flow 50% (FEF50%), the amount of air that is 
forcibly expelled during the first half of the total forced vital 
capacity. 
vi-  The forced expiratory flow 25-75% (FEF25 -75%), the amount of 
air expelled from the lungs during the middle half of the forced vital 
capacity. 
vii- The peak expiratory flow rate (PEF), the highest speed of air 
expired by full expiratory effort following maximum inspiration. 
 
The physiological basis of these tests depends on the development of a 
plateau of expiratory flow at any particular lung volume once a certain 
minimum expiratory pressure is achieved. The values obtained do not 
depend on the pressure applied, but on the mechanical characteristics of the 
lungs and airways.(87) A patient result is expressed in both an absolute 
number and a percentage of his normal predicted value.(88) Values of 
FEV1 and FVC that are over 80% of predicted are defined as within the 
normal range. Normally the FEV1 is about 80% of the FVC. In restrictive 
lung diseases like pulmonary fibrosis, both FEV1 and FVC are reduced, but 
characteristically the FEV1/ FVC ratio is normal or increased. In 
obstructive lung diseases such as asthma, the FEV1 is reduced much more 
than the FVC, giving a low FEV/FVC ratio.(89) The forced expiratory flow 
(FEF25 -75%) is closely related to FEV1 although occasionally it is 
reduced while FEV1 is normal. This is because it has the advantage of 
avoiding measurement during the effort dependent first quarter of the FVC. 
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Both FEV1 and FEF25-75% are reduced by an increase in airway 
resistance or decrease in elastic recoil of the lung. When spirometry is not 
available, the peak expiratory flow rate (PEF) can be measured by the peak 
flow meter. This is a portable, simple and cheap device that can easily be 
used by children. PEF provides simple quantitative measure of airflow 
obstruction. It has been used together with FEV1 ever since 1940.(90) 
Clinical guidelines on asthma management including the British Thoracic 
Society Guidelines (BTS) and the Guidelines of the National Asthma 
Education and Prevention Program of the United States recommend 
measurement of peak expiratory flow rate as part of the routine 
management of a patient with an exacerbation of asthma.(91,92) 
 
Spirometric tests can be performed in children from age 6 year. Patience is 
required, particularly in young and inexperienced children, to obtain 
satisfactory FVC maneuvers; however, most children from age 9 years and 
above met adult-based American Thoracic Society (ATS) goals for 
spirometry test performance.(93) These goals include criteria for 
acceptability and reproducibility (mentioned in the next chapter). 
 
 
1.2.5.2 The Adverse effects on passive smoking on lung functions  
A growing body of scientific evidence indicates that childhood exposure to 
environmental tobacco smoke adversely affects lung function.(60,94-98) 
Several studies suggested that pulmonary function decrement in school-
aged children was a result of combined early life (including intra-uterine 
life) and current exposure to parental smoking, especially the maternal 
smoking.(99-106) However, the negative effect of passive smoking on lung 
function is amplified in children with residual lung insult due to asthma, 
 13
cystic fibrosis or other lung disease.(107,108) Intra-uterine exposure to 
maternal smoking was associated with a large deficit in lung functions in 
children with asthma. This deficit was found to be independent of the 
effects of postnatal environmental tobacco smoke exposure.(107) 
Occasional low level of exposure to cigarette smoke seems to be associated 
with lung function alterations in adolescents.(109) On the other hand, some 
studies reported that intra-uterine exposure had no effect, suggesting that 
passive smoking after birth represents a major contributing factor to 
development and persistence of airflow obstruction or respiratory 
symptoms.(110,111) 
 
 
1.3 Pathophysiology 
1.3.1 Pathophysiology of respiratory diseases 
Cigarette smoke contains over 4000 compounds, many of which are 
extremely reactive affecting the physiology of the respiratory system, 
cardiovascular system and other systems in the body.(15-19) The 
physiological responses to these chemicals in a passive smoker are 
generally the same as those in the active smoker but with a diminished 
effect.  
 
Nicotine, a weak alkaloid consisting of a pyridine and a pyrrolidine rings, 
is the most addictive substance in cigarette smoke and thus sets the stage 
for continued exposure to the other constituents.(112) It meets all the 
criteria that define an addictive substance: it produces brief pleasurable 
psychoactive effects, its use occurs despite the known harmful effects, 
tolerance to both the pleasurable and unpleasant effects develops during 
early usage, higher doses overcome tolerance, and withdrawal symptoms 
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occur when the substance is no longer used.(112) Droplets of tar containing 
nicotine are deposited from cigarette smoke in the small airways and 
alveoli in the lungs where nicotine is buffered to physiological pH and is 
rapidly absorbed into the systemic circulation to reach the brain in about 10 
to 19 seconds.(113) Nicotine acts on cholinergic nicotinic receptors that are 
found in large numbers in the brain. They are also found in sympathetic 
ganglia, parasympathetic ganglia, neuro-muscular junction and adrenal 
medulla.(86) Nicotinic receptors are ligand-gated ion channels that are 
made up of multiple subunits encoded by different genes. In the brain, 
many of these receptors are located presynaptically on glutamine secreting 
neurons. However, most of the other receptors are postsynaptic. 
Stimulation of these receptors by acetylcholine or small amount of nicotine 
results in sodium influx which causes depolarizing potentials followed by 
action potentials.(86) Nicotine has many effects in the body, including a 
pronounced effect on the major stress hormones. It stimulates hypothalamic 
corticotropin-releasing factor, increases levels of endorphins, 
adrenocorticotropic hormone and arginine vasopressin in a dose-related 
manner, releases corticosteroids in proportion to plasma nicotine 
concentration, alters the bioavailability of dopamine and serotonin and 
causes a sharp increase in heart rate and blood pressure.(32,114,115) 
 
The respiratory physiology is also affected by tar, carbon monoxide, 
nitrogen oxides and many other substances found in cigarette smoke. Tar is 
the particulate component of smoke without the water or alkaloid content. 
It contains many carcinogens including polynuclear aromatic 
hydrocarbons, n-nitrosamines and aromatic amines.(116) Carbon monoxide 
binds tightly to hemoglobin in red blood cells forming carboxyhemoglobin. 
This decreases the capacity of the red blood cells to carry oxygen to vital 
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organs resulting in anemic hypoxia.(117) Adults who smoke have higher 
hemoglobin concentrations, which are believed to be a compensatory 
mechanism caused by release of erythropoietin from the kidney in response 
to the carbon monoxide-induced hypoxia.(118) An increased 2,3-
diphosphoglycerate concentration, which alters oxygen's affinity for 
hemoglobin, can be correlated with tobacco smoke in children's 
blood.(117,119) Nitrogen oxides and many other oxidants contribute to the 
inflammatory response induced by cigarette smoking.(120) It is clear that, 
both active and passive exposure to tobacco smoke have a deleterious 
effect on the lung and on oxygen transport in children and adults. 
 
Inflammatory cells in cigarette smokers are found predominantly in the 
lower respiratory tract with marked increase in alveolar macrophages.(121) 
They are typically filled with pigmented debris that is probably derived 
from cigarette smoke and cells injured by the smoke. In addition, 
neutrophils are present within the airway lumen and in the periglandular 
areas.(121) It is likely that cigarette smoke contributes to chronic 
inflammation in the lungs of smokers by activating the epithelial cells that 
line the airways to release proinflammatory cytokines and activating 
alveolar macrophages and complement system, thus generating 
proinflammatory mediators in a cell-independent manner. This probably 
leads to recruitment and activation of the diverse inflammatory cells 
present in the lungs of smokers.(122,123) Inflammation of the airway 
epithelium results in increased mucus production, decreased ciliary 
movement, beat frequency and transport, increased mucosal permeability to 
allergens, associated with increased total and specific immunoglobulin E 
levels in the blood and increased blood eosinophil counts.(124,125)  
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1.3.2 Inflammatory markers 
Inflammatory markers such as IL-1, IL-4, IL-6, IL-8, TNFα, IFNγ and CRP 
can provide information about the mechanism of the inflammatory 
reactions associated with many respiratory and cardiovascular 
diseases.(126-132) These inflammatory markers or cytokines are hormone-
like molecules that act generally in a paracrine fashion, to regulate immune 
responses.(86) They are secreted not only by activated lymphocytes and 
macrophages, but also by endothelial cells, bronchial epithelial cells and 
other types of cells. The effects of these cytokines include activation of T 
lymphocytes and promotion of inflammation (IL-1), activation of 
lymphocytes, monocytes and IgE class switching (IL-4), activation of 
lymphocytes and production of acute phase proteins (IL-6), chemotaxis for 
neutrophils, basophils and T lymphocytes (IL-8) and promotion of 
inflammation (TNF-α).(86) In many case control studies, the level of 
inflammatory markers was measured in body fluids of smokers and non 
smokers. Many of these studies found higher levels of inflammatory 
markers in serum, plasma or broncho-alveolar fluid of active and passive 
smokers compared to non-smokers.(133-137) However, some studies did 
not find any difference in concentration of these cytokines between passive 
smokers and non-smokers.(138-139) This variation in the pro-
inflammatory responses may be due to genetic factor polymorphism and it 
may explain why certain individuals are more susceptible to the negative 
effects of smoking more than others.(140) 
 
 
1.3.2.1 C-Reactive Protein  
C - reactive protein (CRP) is an acute phase glycoprotein produced 
exclusively in the liver, in response to inflammatory cytokines such as IL-
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6.(141,142) Its molecular weight is 120-140 kD. Although its structure is 
distinct from the immunoglobulins, it shares with them many biological 
activities. For example, it activates complement,(143) acts as an opsonin 
(144) and participates in generation of cytokines that enhance 
inflammation.(128) Its normal concentration in serum is less than 5 mg/L. 
Its level rises significantly in infectious and non infectious inflammation, 
tissue damage and in the presence of malignant tumors. For this reason, 
quantitative measurement of CRP is increasingly used as a marker of 
inflammation and tissue necrosis.(145) Because its biological half-life is 
less than 24 hours, concentration of CRP decreases much faster than ESR; 
that is why it is useful in follow up of the inflammatory process and in 
monitoring the response to treatment.(145) Passive smokers who are 
exposed regularly to environmental tobacco smoke have significantly 
higher C-reactive protein levels in plasma (146-148) indicating an ongoing 
inflammatory process. Several studies now support a strong link between 
baseline elevations of CRP and future risk of coronary events.(130,149) 
However, Helmersson et al. found no difference in serum CRP between 
smokers and non-smokers.(150) 
 
1.3.2.2 Interleukin 4 
Interleukin 4 (IL-4) is a 14 kD protein containing 130 amino acid residues. 
It is a potent multifunctional cytokine produced by activated T 
lymphocytes, mast cells and basophils. It stimulates growth and 
differentiation of B lymphocytes and maintains viability of certain subsets 
of B & T lymphocytes. In addition, it exerts a variety of biological effects 
on many non-lymphoid cells including endothelial cells and fibroblasts. 
Cigarette smoking has been associated with increased serum levels of total 
IgE and an increased risk of developing allergic-like symptoms.(151,152) 
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IL-4 and interferon-gamma (IFN-gamma) have reciprocal roles in the 
regulation of IgE synthesis. It is found that IL-4 production by peripheral 
blood mononuclear cells of smokers is significantly higher than that of non-
smokers.(152) However, IFN-gamma production is not increased. This 
imbalance, favoring IL-4 production, may be part of the mechanism 
responsible for the observed increases in serum IgE and allergic-like 
symptoms associated with cigarette smoking.(152) 
 
1.3.2.3 Tumor Necrosis Factor-α 
Tumor necrosis factor alpha (TNF-α) is an extremely potent peptide 
cytokine (17 kD) that serves as an endogenous mediator of inflammatory, 
immune and host defense functions.(153-154) Several substances originally 
described for their biological activities, e.g. cachectin, macrophage 
cytotoxin (MCT) and necrosin, have been identified later as TNF-
α.(155,156) TNF is produced mainly by macrophages in response to many 
bacterial, viral and parasitic products.(157) (e.g. lipopolysaccharides), but it 
is produced also by other cell types in response to IL1.(158)  
 
TNFα has a broad spectrum of biological activities.(159-161) It acts either 
independently or in conjunction with other cytokines like IL1.(162) A local 
increase in concentration of TNFα will cause the cardinal signs of 
inflammation to occur: heat, swelling, redness, and pain; prolonged 
exposure to low concentrations can result in cachexia whereas high 
concentrations of TNFα induce shock-like symptoms. Other effects include 
the following: 
i. Stimulation of the hypothalamus to release corticotrpin releasing 
hormone (CRH) 
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ii. Fever 
iii. Inhibition of appetite 
iv. Stimulation of the liver to release the acute phase proteins like cRP  
v. Stimulation of chemotaxis for neutrophils and facilitation of 
diapedisis 
vi. Stimulation of macrophages to phagocytose microorganisms and 
release IL1 and prostaglandin E2 (PGE2) 
Many studies confirmed that TNFα production and concentrations in body 
fluids were greater in smokers than in non-smokers.(163-165) However, 
some attempts to examine the effect of cigarette smoking on TNFα 
production reported insignificant results.(166,167) Recent studies have 
shown that TNFα plays an important role in the induction of the cigarette 
related COPD and in the maintenance of airway inflammation.(168,169) 
 
 
1.4 Justification 
Passive smoking is a cause of lung cancer and ischemic heart disease in 
adults and a cause of respiratory disease, cot death, middle ear disease and 
asthmatic attacks in children. Genetic factors appear to play a role in 
determining who will be affected more by smoking; in a comparative study 
of lung function in relation to passive smoking between American and 
French women, passive smoking was found to be significantly related to 
lower FVC and FEV1 values among the French women but not the 
American ones.(140)  In another study, the importance of cytokine genetic 
polymorphism in determination of who is going to develop cigarette 
induced chronic obstructive pulmonary disease was documented.(170) 
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Taking the dangerous hazards of active and passive smoking into 
consideration, the World Health Organization Framework Convention on 
Tobacco Control calls for nations to establish progressively a national 
system for the epidemiological surveillance of tobacco consumption and 
related social, economic and health indicators.(171) In this regard, the 
adverse health effects of tobacco products, especially toombak, on 
Sudanese subjects is well investigated.(172-183) The Department of 
Physiology has investigated the short term effects of tobacco smoke on the 
respiratory system in adults.(44,184) However, the effect of passive 
cigarette smoking on the respiratory system in school children and its 
relation to the level of inflammatory markers in the plasma is not covered.   
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1.5 Objectives 
1.5.1 General objective 
i. To determine the effects of passive smoking on spirometric values 
and plasma level of inflammatory markers in healthy male 
school-children. 
 
1.5.2 Specific objectives 
i. To compare results of spirometry between passive smokers and 
non-smokers by measuring ventilatory functions of the lung in 
healthy male school-children using a spirometer. 
ii. To measure plasma level of the inflammatory markers (IL4, CRP 
and TNFα) in healthy male school-children in order to compare 
between passive smokers and non-smokers. 
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2. SUBJECTS AND METHODS 
2.1 Study design 
This is an analytic observational case control study. 
 
2.2 Study area and population 
The study was conducted in three governmental primary schools for boys 
in Khartoum (Arkweet Shamal in Arkweet, Elshaheed Muatasim Parakat in 
Imtidad Naser  & Alimtidad 1 in Alimtidad Eldarga 3), between August 
2006 and January 2009. The schools were selected randomly from 92 
primary schools, the total number of public schools for boys in Khartoum. 
Each school contains 8 classes, in each class there are about 40 to 60 
pupils; their ages range from 6 to 15 years old. All pupils in the three 
schools were approached. Inclusion and exclusion criteria were used to 
select the test and control groups. The selected pupils were 9 to 14 years 
old, in the fourth to the seventh grades. Parents of the pupils were generally 
of the average socio-economic class. They lived in houses near the schools 
of their children. Most of the fathers were manual workers or employees 
whereas the majority of the mothers were housewives.  
 
2.3 Sample size 
The sample size of each group (test and control groups) was calculated 
using the formula: n> 2[(z2α + z2β)σ/δ1]2; where n= the sample size, z= the 
standardized deviate, α= type I error, β= type II error, σ= the standard 
deviation & δ= the true difference.(185) The calculated result for each 
group (test or control group) was 63. About 573 pupils were approached 
and only 135 of them fulfilled the inclusion criteria. Those included in the 
test group were 69 pupils whereas the other 66 pupils were included in the 
control group. 
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2.4 Inclusion and exclusion criteria 
Inclusion criteria for the test group were: school-pupil, age 9 - 14 years, 
healthy with normal BMI, has no symptoms or signs of acute or chronic 
medical illness during the last four weeks, no signs of respiratory disease or 
chest deformity, not on medical treatment, not active smoker, living with at 
least one smoker at home, exposed regularly to cigarette smoke at home of 
not less than two cigarettes per day for most days, since birth and not 
regularly exposed to environmental tobacco smoke or any other type of 
smoke outside the house.  
 
Inclusion criteria for the control group were: school-pupil, age 9 - 14 years, 
healthy with normal BMI, has no symptoms or signs of acute or chronic 
medical illness during the last four weeks, no signs of respiratory disease or 
chest deformity, not on medical treatment, not active smoker and not 
exposed to environmental tobacco smoke or any other type of smoke inside 
or outside the house.  
 
Exclusion criteria for both groups were: age less than 9 or more than 14 
years, abnormal BMI, presence of symptoms of acute or chronic medical 
illness during the last four weeks, presence of abnormal chest signs or 
skeletal deformity on clinical examination, being on medical treatment, 
active smoker, exposed to cigarette smoke or any other type of smoke 
inside or outside the house (for the group of controls) or exposed to smoke 
of less than two cigarettes per day inside the house (for the group of cases). 
 
Both groups were matched according to age, sex, height, weight and area of 
residence. The nutritional status (assessed by BMI) of the two groups was 
also considered.  
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2.5 Methods  
2.5.1 Questionnaire 
Four “interviewer administered questionnaire papers” were prepared (see 
appendix). Data required by the questionnaire papers were collected from 
each pupil and his parents as follows:  
i. Information collected from the pupil was about his age, class, school 
performance, health problems, smoking habits, exposure to 
environmental cigarette smoke at home or outside the house, 
frequency of exposure, exposure to any other type of smoke in or 
outside the house, number of smokers in the house and who is 
smoking. 
ii. Information collected from the father of the pupil was about the 
father’s age, tribe, address, educational attainment, job, health 
insurance, smoking habits, his knowledge about the adverse health 
effects of passive smoking and his attitude and behavior towards 
smoking at home, near his children or near his wife during pregnancy. 
iii. Information collected from the mother of the pupil was about the 
mother’s age, address, educational attainment, job, smoking habits, 
her knowledge about the adverse health effects of passive smoking 
and her attitude and behavior towards smoking at home, near her 
children or during pregnancy. 
iv. Information about the pupil’s health status was collected from the 
parents. It included information about the present health status of their 
child, wheezes, allergy, snoring at sleep, past history of hospital 
admissions, surgical operations and history of infections like 
pneumonia, influenza and otitis media during the last year. The 
questionnaire paper also requested a signed permission to take a blood 
sample and to test the lung function of their child using a spirometer.  
 26
2.5.2 Evaluation of the degree of exposure 
The information obtained from each pupil and his family about the degree 
of exposure to cigarette smoke at home was used for classification of the 
pupils into three subgroups: group of no exposure (includes all the 
controls), group of mild-moderate exposure (exposed to smoke of 2 to 5 
cigarettes/day) and group of heavy exposure (exposed to smoke of > 5 
cigarettes/day). 
 
2.5.3 Clinical examination:  
The selected pupil was examined clinically to exclude presence of any 
abnormal clinical sign that might interfere with the normal function of his 
respiratory system such as pleural effusion, pneumothorax, asthma and 
signs of chest deformity or skeletal abnormality. The height and weight of 
each pupil were measured using standardized height and weight scales. The 
Body mass index (BMI) was calculated for each pupil as weight (in 
kilograms)/height (in meters2). The BMI results were compared to normal 
values of BMI adjusted for age and sex.(218)  
 
2.5.4 Spirometry 
A portable spirometer (Clement Clarke All-flow Spirometer) was used to 
measure FVC, FEV1, FEF50 and PEF for each pupil. Measurements were 
carried out according to the guidelines of the American Thoracic 
Society.(186) These guidelines provide criteria for standardization of 
spirometry performance, including criteria for acceptability and 
reproducibility of the test results.  
2.5.4.1 Criteria for acceptability: 
i. Lack of artifact induced by coughing, glottis closure or 
equipment problems 
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ii. Satisfactory start to the test without hesitation 
iii. Satisfactory exhalation with six seconds of smooth continuous 
exhalation and/or a plateau in the volume time curve of at least 
one second, or a reasonable duration of exhalation with a 
plateau. 
2.5.4.2 Criteria for reproducibility (after three acceptable results): 
i. The largest FVC should be within 0.2 L of next largest FVC  
ii. The largest FEV1 should be within 0.2 L of next largest FEV1 
iii. If these two criteria are not met, additional spirograms should 
be obtained up to eight efforts.  
iv. The largest values of FVC, FEV1, FEF50 and PEF are reported. 
2.5.4.3 Measurement steps: 
i. Air temperature and relative humidity of the room were 
measured and registered in a computer program that controls 
the spirometer.  
ii. The spirometer was calibrated with a 3L calibrating syringe. 
iii. The age, sex, height and weight of each pupil were registered 
in the computer program. 
iv. Each pupil was asked to stand up, clip his nose with a nose 
clip, take a deep breath, put a mouthpiece connected to the 
spirometer in his mouth with the lips tightly around it, and 
then blow air out as hard and as fast as possible for at least 6 
seconds.  
v. The procedure was repeated according to the ATS criteria 
(mentioned above) until acceptable and reproducible results 
were obtained.  
vi. Total measurement trials for each pupil did not exceed eight 
times to avoid exhaustion. 
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2.5.5 Collection of blood Samples 
Chemically clean and sterile disposable needles, syringes and swabs 
were used for all blood samples. About 5 ml of blood was withdrawn 
from each pupil from the antecubital vein. The blood was collected in 
a tube containing EDTA as an anticoagulant. Then the tube was 
sealed, labeled with the pupil’s number, incubated in ice and sent 
immediately to the laboratory for full blood counts and plasma 
separation. 
 
2.5.6 Plasma separation and storage 
Plasma was prepared with centrifugation within two hours of 
venipuncture. Plasma samples were frozen and stored at -20 оC for 
biochemical analysis. 
 
2.5.7 Technique of biochemical analysis 
2.5.7.1 General principles 
The inflammatory markers IL4, TNFα and CRP were measured using 
commercially available quantitative sandwich enzyme-linked immuno-
sorbent assay (ELISA) kits according to instructions of the 
manufacturers. The analyses were performed with 96-well microtiter 
plate ELISA kits for IL4 & TNFα (from BD Biosciences 
Pharmingen/USA), and NycoCard Reader II quantitative test for CRP 
(from Axis-Shield/Norway). Test sensitivity was 2 pg/ml for IL4, 2 
pg/ml for TNF-α, and 5 mg/L for CRP. Microtiter strips pre-coated 
with monoclonal antibodies generated against the proteins were used 
for quantification.  
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2.5.7.2 ELISA Procedure 
i. 50 µL ELISA diluent (a buffered protein base with 0.09% 
sodium azide as preservative) was added to each well. 
ii. 100 µL standard (animal serum with 0.09% sodium azide as 
preservative) or sample was added to each well and incubated 
for two hours at room temperature. 
iii. The mixture was aspirated and washed with concentrated 
detergent solution for 5 times. 
iv. 100 µL prepared working detector (biotin-conjugated 
antibody) was added to each well and incubated for one hour 
at room temperature. 
v. The mixture was aspirated and washed with concentrated 
detergent solution for 7 times.  
vi. 100 µL TMB One-Step Substrate Reagent (3,3’,5,5’-
tetramethylbenzidine in a buffered solution) was added to each 
well and incubated for 30 minutes at room temperature. 
vii. 50 µL stopping solution (1 M phosphoric acid) was added to 
each well and the intensity of the color was measured at 450 
nm within 30 minutes.  
 
2.6 Ethical consideration 
The research conforms to the ethical principles of medical research 
developed by the World Medical Association Declaration of Helsinki.(187) 
Ethical approval was given by the Research Committee (Faculty of 
Medicine/ University of Khartoum). Approval was obtained from the Unit 
of School Health/ Ministry of Education. Permission letters were submitted 
to the headmasters of the selected schools. Written consents were obtained 
from the parents before entry into the study. 
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2.7 Statistical analysis 
All data obtained with questionnaire, spirometry and biochemical analysis 
was analyzed using the Statistical Package for the Social Sciences (SPSS) 
version 14. The chi square test was used to test distribution of categorical 
variables and student's t test was used for continuous variables. The 
difference between the test and the control groups were assessed with the 
student's t test. Statistical significance was accepted when P value is less 
than 0.05.  
 
2.8 Data presentation 
Final results were presented in tables and figures. 
 
2.9 Declaration 
Almost all phases of this research and most technical methods of data 
collection were done by me. These include obtaining the ethical approval 
from the educational authorities, coverage of half of expenses of training 
courses on spirometric measurements, standardization and interpretation at 
Royal Brompton Hospital in London/ United Kingdom, courses on 
statistical analysis using the SPSS program, random selection of the 
schools and the pupils, questionnaire application, collection of information 
from each pupil and his parents, clinical examination, BMI measurements, 
lung function test measurements, plasma separation and storage and 
statistical analysis; however, the technical parts that need special 
experience were done by trained laboratory technicians during my 
attendance and under my supervision. These include the process of blood 
collection from the pupils and the biochemical analysis.   
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3. RESULTS 
3.1 Demographic characteristics of the study group 
3.1.1 Age distribution 
The ages of school pupils in the study group ranged between 9 and 14 
years old with a mean of 11.6 ± 1.3 year (mean ± SD). (Fig. 1) 
 
The mean age for the group of cases was 11.7 ± 1.3 year and for the 
group of controls was 11.5 ± 1.2 year. There was no significant 
statistical difference in age distribution between the two groups. (Table 
1), (Fig. 2) 
 
3.1.2 Height distribution 
The height of school pupils in the study group ranged between 121 and 
170 cm, with a mean of 144.13 ± 9.00 cm. It showed normal 
distribution curve. (Fig. 3) 
 
The mean height for the group of cases was 144.25 ± 9.85 cm and for 
the group of controls was 144.00 ± 8.19 cm. There was no significant 
statistical difference in height distribution between the two groups. 
(Table 1), (Fig. 4) 
 
3.1.3 Weight distribution 
The weight of school pupils ranged between 21 and 50 kg, with a mean 
of 34.79 ± 6.28 kg. (Fig. 5) 
 
The mean weight for the group of cases was 34.99 ± 6.83 kg and for the 
group of controls was 34.58 ± 6.69 kg. There was no significant 
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statistical difference in weight distribution between the two groups. 
(Table 1) 
 
3.1.4 Body mass index (BMI) distribution: 
The BMI for pupils in the study group ranged between 13.92 and 21.7, 
with a mean of 16.63 ± 1.72.  
 
The mean BMI for the group of cases was 16.66 ± 1.72 and for the 
group of controls was 16.60 ± 1.73. There was no significant statistical 
difference in BMI distribution between the two groups. (Table 1) 
 
3.1.5 Blood cells, hemoglobin & red blood cell indices 
Complete blood count showed the following values in the study group: 
mean WBC count was 6.42 ± 2.24 /µL, mean RBC count was 4.75 ± 
0.49 /µL, mean hemoglobin concentration was 11.9 ± 1.10 g/dL and 
mean packed cell volume was 35.95 ± 3.25%. 
 
Statistical analysis did not show significant statistical difference in the 
results of complete blood count between the group of cases and that of 
controls. (Table 2) 
 
3.1.6 Sources of second-hand smoke in the study group 
Fathers were responsible for 67% of passive smoking in the group of 
cases. Mothers were responsible for about 2% whereas relatives like 
brothers and uncles were responsible for about 30%. (Fig. 6) 
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3.2 Effect of passive smoking on plasma level of inflammatory markers 
3.2.1 Effect on plasma CRP 
The mean plasma CRP was 1.13 ± 0.34 mg/L (mean ± SEM) in the 
group of cases and 0.47 ± 0.25 mg/L in the group of controls. 
Although the mean was higher in the group of cases than in the group 
of controls, the difference was not statistically significant. (Table 3) 
 
The mean plasma CRP was 0.47 ± 0.25 mg/L in those who were not 
exposed to cigarette smoke (group of no exposure), 1.04 ± 0.36 mg/L 
in the group of mild-moderate degree of exposure and 1.32 ± 0.72 
mg/L in the group of high degree of exposure. The level was higher in 
those with mild-moderate exposure than those with no exposure; and 
highest in those with high degree of exposure. The difference between 
the three groups was not statistically significant. (Table 4) 
 
3.2.2 Effect on plasma IL4 
The mean plasma IL4 was 2.92 ± 0.93 pg/ml in the group of cases and 
0.45 ± 0.28 pg/ml in the group of controls. The difference between the 
two groups was statistically significant (P < 0.05). (Table 3) 
 
When the degree of exposure was considered, the mean plasma IL4 
was lowest (0.45 ± 0.28 pg/ml) in those who were not exposed to 
cigarette smoke, higher (2.72 ± 1.24 pg/ml) in those with mild-
moderate degree of exposure and highest (3.33 ± 1.24 pg/ml) in those 
with high degree of exposure. The difference between the three groups 
was statistically significant (P < 0.05). (Table 4) 
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3.2.3 Effect on plasma TNF-α 
The mean plasma TNFα was higher in the group of cases (19.78 ± 4.67 
pg/ml) than the group of controls (5.05 ± 1.54 pg/ml). This difference 
was statistically significant (P < 0.05). (Table 3) 
 
The mean plasma TNFα was 5.05 ± 1.54 pg/ml in those who were not 
exposed to cigarette smoke, 12.42 ± 3.23 pg/ml in those with mild-
moderate degree of exposure and 35.50 ± 12.47 pg/ml in those with 
high degree of exposure. The level was higher in those with mild-
moderate exposure and highest in those with high degree of exposure. 
The difference between the three groups was found to be statistically 
significant (P < 0.05). (Table 4) 
 
 
3.3 Effect of passive smoking on spirometric values 
3.3.1 Effect on FVC 
The mean FVC was 2.41 ± 0.35 L (mean ± SD) in the group of controls 
and 2.21 ± 0.57 L in the group of cases (reduction by about 8%). The 
difference between the means of the two groups was statistically 
significant (P < 0.05). (Table 5) 
 
The mean FVC was highest (2.41 ± 0.35 L) in those who were not 
exposed to cigarette smoke, lower (2.24 ± 0.60 L) in those with mild-
moderate degree of exposure and lowest (2.15 ± 0.51 L) in those with 
high degree of exposure to cigarette smoke. However, the difference 
between the three groups was not statistically significant. (Table 6) 
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3.3.2 Effect on FEV1 
The mean FEV1 was lower in the group of cases (2.03 ± 0.46 L) than 
the group of controls (2.20 ± 0.42 L) by about 7%. This difference was 
found to be statistically significant (P < 0.05). (Table 5) 
 
When the degree of exposure was considered, the mean FEV1 was 2.20 
± 0.41 L in those who were not exposed to cigarette smoke, 2.07 ± 0.47 
L in those with mild-moderate degree of exposure and 1.95 ± 0.42 L in 
those with high degree of exposure. Although there is progressive 
reduction in the value of FEV1, showing a dose related response to 
cigarette smoke exposure; the difference between the three groups was 
not statistically significant. (Table 6) 
 
3.3.3 Effect on FEF50 
The mean FEF50 was 3.24 ± 0.77 L/s in all school pupils of the study 
group, 3.20 ± 0.73 L/s in cases and 3.28 ± 0.81 L/s in controls. The 
mean was lower in the group of cases than in controls; however, this 
difference was not statistically significant. (Table 5) 
 
When the degree of tobacco smoke exposure was considered, the mean 
FEF50 was 3.27 ± 0.81 L/s in those who were not exposed to cigarette 
smoke, 3.29 ± 0.76 L/s in those with mild-moderate degree of exposure 
and 3.02 ± 0.66 L/s in those with high degree of exposure. The mean is 
lower in those with high degree of exposure than those without or with 
mild-moderate degree of exposure. However, the difference was not 
statistically significant. (Table 6) 
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3.2.4 Effect on PEF 
The mean PEF was 4.42 ± 0.97 L/s in the group of cases and 4.54 ± 
0.63 L/s in the group of controls. It is lower in the group of cases than 
the group of controls; however, this difference was not statistically 
significant. (Table 4) 
 
The mean PEF was 4.54 ± 0.63 L/s in those who were not exposed to 
cigarette smoke, 4.41 ± 1.07 L/s in those with mild-moderate degree of 
exposure and 4.45 ± 0.76 L/s in those with high degree of exposure. 
The difference between the three groups was not statistically 
significant. (Table 6) 
 
 
3.4 Knowledge and attitude of parents towards passive smoking 
3.4.1 Educational attainment of fathers in the study group 
About 21% of all fathers were primary school graduates, 12% were 
intermediate school graduates, 39% were higher secondary school 
graduates, 17% were university graduates and about 10% were non-
educated. The percentage of passive smoking was low in children of 
non-educated and university graduate fathers, and high among children 
whose fathers received primary, intermediate secondary or higher 
secondary school education. The difference in educational attainment 
between fathers of the group of cases and fathers of the group of 
controls was not statistically significant. (Fig. 7) 
 
3.4.2 Educational attainment of mothers in the study group 
About 21% of all mothers completed primary school education, 15% 
completed intermediate secondary school education, 34% completed 
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higher secondary school education, 15% were university graduates and 
about 15% were non-educated. The percentage of passive smoking was 
low in children of non-educated mothers or those who received higher 
secondary school education. It was higher among children whose 
mothers received primary, intermediate secondary or university 
education. However, the difference in educational attainment between 
mothers of the two groups (cases & controls) was not statistically 
significant. (Fig. 8) 
 
3.4.3 Knowledge about adverse effects of passive smoking 
The majority of parents in the study group (82%) believed that passive 
smoking is associated with complications and adverse effects on child’s 
health, with slightly higher percentage for the parents of controls (88% 
of all controls) than the parents of cases (75% of all cases); however, 
this difference was not statistically significant. (Fig. 9) 
 
3.4.4 Attitude of fathers towards smoking near their wives during     
pregnancy  
All fathers of the pupils in the group of controls and the majority (90%) 
of fathers of the pupils in the group of cases did not smoke or allow 
relatives to smoke near their wives during pregnancy.  The remaining 
10% of all fathers in the study group smoked near their wives during 
pregnancy. The difference between fathers of the group of cases and 
fathers of the group of controls was statistically significant (P < 0.05). 
(Fig. 10) 
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3.5 Effect of passive smoking on child’s health and school 
performance 
3.5.1 Hospital admissions among cases and controls 
About 21% of all pupils in the study group had positive past history of 
hospital admission for more than 24 hours. About half of these pupils 
(10.37%) were in the group of cases and the other half were in the 
group of controls. There was no significant statistical difference 
between the two groups. (Fig. 11) 
 
3.5.2 Surgical operations among cases and controls 
About 9% of all pupils in the study group had a past history of surgical 
operation. About two thirds were from the group of cases and the rest 
were from the group of controls. Although the percentage of operations 
was higher in the group of cases than the group of controls, statistical 
tests did not show any significant difference between the two groups. 
(Fig. 12) 
 
3.5.3 Childhood illnesses among cases and controls 
The percentage of pupils who had influenza like illness during the last 
year was higher in the group of cases (14.8%) than the group of 
controls (9.6%). However, this difference was not statistically 
significant. (Fig. 13) 
 
The percentage of pupils who had pneumonia was higher in the group 
of cases (6.7%) than the group of controls (3.7%). However, no 
significant statistical difference was found between the two groups. 
(Fig. 13) 
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Positive past history of otitis media was higher in the group of cases 
(2.2%) than the group of controls (1.5%). However, the difference 
between the two groups was not statistically significant. (Fig. 13) 
 
3.5.4 Snoring among cases and controls 
Snoring during sleep was higher in the group of cases (8.2%) than the 
group of controls (2.2%). Statistical tests show significant difference 
between the two groups (P < 0.05). (Fig. 14) 
 
3.5.5 School performance among cases and controls 
The percentage of pupils with excellent academic performance in the 
last school examination was (5.9%) in the group of cases and (9.6%) in 
the group of controls. On the other hand, the percentage of pupils with 
weak performance was higher in the group of cases (20.0%) than the 
group of controls (15.6%). However, the difference between the two 
groups was not statistically significant. (Fig. 15) 
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Table 1: Age, Height, Weight & Body Mass Index among Cases & 
Controls in the Study Group 
 
 
 
 
 
 Cases (n = 69) Controls (n = 66) 
Parameter Mean ± SD Min Max Mean ± SD Min Max 
Age (y) 11.70 ± 1.34 9.0 14.0 11.53 ± 1.2 9.0 14.0 
Height (cm) 144.24 ± 9.85 121 170 144.00 ± 8.19 128 166 
Weight (Kg) 34.99 ± 6.83 21 50 34.58 ± 5.69 25 50 
BMI 16.66 ± 1.72 13.92 21.36 16.60 ± 1.73 14.18 21.7 
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Table 2: Mean White Blood Cell Count, Red Blood Cell Count, 
Hemoglobin Concentration & Packed Cell Volume among Cases & 
Controls in the Study Group 
 
 
 
 
 
 Cases (n = 69) Controls (n = 66) Normal  
 
value* Parameter Mean ± SD Mean ± SD 
TWBC (x103 cell/µL) 6.39 ± 2.26 6.45 ± 2.23 4.50-13.50 
RBC (x106 cell/µL) 4.75 ± 0.48 4.74 ± 0.49 3.8-5.5 
Hb (g/dL) 11.97 ± 0.99 11.83 ± 1.2 11-16 
PCV (%) 36.33 ± 3.33 35.56 ± 3.16 34-40 
* Source: Nelson Essentials of Pediatrics (5th edition) 
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Table 3: Mean Plasma Levels of Inflammatory Markers among Cases 
& Controls in the Study Group 
 
 
 
 
 
 Cases (n = 69) Controls (n =66) 
Parameter Mean ± SEM Mean ± SEM 
CRP (mg/L) 1.13 ± 0.34 0.47 ± 0.25 
IL4 (pg/ml) 2.92 ± 0.93* 0.45 ± 0.28 
TNFα (pg/ml) 19.78 ± 4.67* 5.05 ± 1.54 
P* < 0.05 
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Table 4: Plasma Levels of Inflammatory Markers According to Degree 
of Cigarette Smoke Exposure (Mean ± SEM) 
 
 
 
 
 
Parameter 
No exposure 
(n=66) 
Mild-moderate 
exposure (n=47) 
High exposure 
(n=22) 
Mean ± SEM Mean  ± SEM Mean ± SEM 
cRP (mg/L) 0.47 ± 0.25 1.04 ± 0.36 1.32 ± 0.72 
IL4 (pg/ml) 0.45 ± 0.28   2.72 ± 1.24*   3.33 ± 1.24* 
TNFα (pg/ml) 5.05 ± 1.54 12.42 ± 3.23*   35.50 ± 12.47* 
P* < 0.05 
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Table 5: Distribution of Mean Spirometric Values among Cases & 
Controls in the Study Group 
 
 
 
 
 
 Cases Controls 
Parameter Mean ± SD Mean  ± SD 
FVC (L)   2.21 ± 0.57* 2.41 ± 0.35 
FEV1 (L) 
FEF50 (L/s) 
  2.03 ± 0.46* 
3.20 ± 0.73 
2.20 ± 0.42 
3.28 ± 0.81 
PEF (L/s) 4.42 ± 0.97 4.54 ± 0.63 
P* < 0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 46
Table 6: Distribution of Mean Spirometric Values According to Degree 
of Cigarette Smoke Exposure 
 
 
 
 
 
Parameter 
No exposure 
(n=66) 
Mild-moderate 
exposure (n=47) 
High exposure 
(n=22) 
Mean ± SD Mean ± SD Mean ± SD 
FVC (L) 2.41 ± 0.35 2.24 ± 0.60 2.15 ± 0.51 
FEV1 (L) 2.20 ± 0.41 2.07 ± 0.47 1.95 ± 0.42 
FEF50 (L/s) 
PEF (L/s) 
3.27 ± 0.81 
4.54 ± 0.63 
3.29 ± 0.76 
4.41 ± 1.07 
3.02 ± 0.66 
4.45 ± 0.76 
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Figure 1: Age Distribution in the Study Group 
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Figure 2: Age Distribution among Cases and Controls in the Study 
Group 
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Figure 3: Height Distribution in the Study Group 
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Figure 4: Height Distribution among Cases and Controls in the Study 
Group 
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Figure 5: Weight Distribution among Cases and Controls in the Study 
Group 
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Figure 6: Sources of Second Hand Smoke in the Study Group 
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Figure 7: Educational Attainment of Fathers in the Study Group 
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Fig 8: Educational Attainment of Mothers in the Study Group 
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Figure 9: Knowledge of Fathers about Adverse Effects of Passive 
Smoking on Child’s Health 
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Figure 10: Attitude of Fathers towards Smoking near their Pregnant 
Wives 
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Figure 11: Past History of Hospital Admissions among Cases and 
Controls in the Study Group 
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Figure 12: Past History of Surgical Operations among Cases and 
Controls in the Study Group 
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Figure 13: Illnesses during the Last Year among Cases & Controls in 
the Study Group 
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Figure 14: Sleep Snoring among Cases and Controls in the Study 
Group 
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Figure 15: School Performance among Cases and Controls in the 
Study Group 
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4. DISCUSSION 
 
4.1 Effect of passive smoking on spirometric values 
The effects of passive smoking on ventilatory functions of the lung in 
children and adolescents were assessed in many studies worldwide. The 
results of these studies were controversial. Some studies found significant 
association between passive smoking and impaired lung function (188-190) 
whereas others did not.(191-193) Some studies reported sex differences in 
vulnerability to the negative effects of passive smoking, with females being 
affected more than males; others reported different results and related the 
negative effects to maternal smoking rather than paternal smoking.(99-106) 
The variation in the effect of passive smoking on lung function in children 
at the school age were attributed to many reasons. It may be related to 
differences in genetic factors or variation in environmental factors, life 
styles and housing conditions of different communities.  
 
In this study, the mean spirometric values (FVC, FEV1, FEF50 & PEF) were 
all lower in children exposed to environmental tobacco smoke at home than 
those who were not exposed. The significant reduction in FVC and FEV1 
(by 7-8%) suggested that indoor environmental tobacco smoke did have 
negative effects on lung function of our male children. Although the results 
were lower in children with high degree of exposure than those with no or 
with mild-moderate degree of exposure, this effect was not statistically 
significant; however, it indicated a dose related effect of passive smoking 
on the degree of reduction in lung function. Genetic vulnerability of the 
children and inadequate ventilation of their housing environment could be 
involved in this reduction in lung function. The vulnerability of the lungs in 
Sudanese subjects to the adverse effects of respirable particles such as 
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cotton dust, flour dust and other particles was confirmed in many previous 
studies.(194-198) On the other hand, inadequate ventilation prevents 
exchange of the indoor air, which is saturated with tobacco smoke, with the 
outdoor air. This exchange is supposed to decrease the concentration of 
gases and particulates in tobacco smoke such as nicotine, polyacrylic 
hydrocarbons, carbon monoxide, acrolein and nitrogen dioxide; thus 
lowering the negative effects of passive smoking on lung function, but this 
needs further study to be confirmed. 
 
 
4.2 Effect on plasma TNF-α 
Cigarette smoke can impair pulmonary immune function and initiate 
release of inflammatory mediators and hence influences the development of 
lung diseases. Recent studies have shown that TNFα plays an important 
role in the induction of the cigarette related COPD and in the maintenance 
of airway inflammation.(199) Experimental studies in rats exposed to 
tobacco smoke confirmed the rise in TNFα in both serum and broncho-
alveolar lavage fluid.(135,165)  
 
In this study, a significant rise in plasma level of TNFα was detected in the 
group of passive smokers compared to the control group. This finding 
indicated that inflammation within the airways of passive smokers was 
established and there would be a risk of progression to COPD with 
continuous exposure to tobacco smoke. The contribution of passive 
smoking to the pathogenesis of COPD and its related mortality was not 
studied in Sudan; however, worldwide, passive smoking is considered as an 
important risk factor for 10-15% of COPD deaths that are not attributed to 
active smoking.(200, 201) In addition, a large proportion of the active 
 65
smokers who suffer from COPD have been passive smokers during their 
childhood. 
 
 
4.3 Effect on plasma IL4 
It was proposed that tobacco smoke modifies CD4/CD8 ratio of T cells, 
increases T helper cells type 2 and increases IL4/IFNγ ratio, either by 
increasing IL4 or decreasing IFNγ, resulting in activation of B cells to 
produce IgE antibodies.(151,152) El-nawawy and colleagues in 1996 
conducted a research in Egypt on the effects of passive smoking on 
frequency of respiratory illnesses, serum IgE and IL4.(202) They found 
higher frequency of respiratory illnesses per year, significantly higher total 
leucocyte count, higher percentage of eosinophils, and higher serum IgE 
and IL4 concentrations in children of smoking parents compared to the 
control group. Oryszczynin et al. reported similar rise in IgE antibodies in 
adults.(203) In this study, the rise in plasma level of IL4 in passive smokers 
was statistically significant. On the other hand, a significant rise in plasma 
IL4 was detected in the pupils with high degree of exposure to tobacco 
smoke compared to the other pupils; again indicating a dose related effect.  
 
 
4.4 Effect on plasma CRP 
The acute phase protein “C-Reactive Protein (CRP)” is a well studied 
marker of systemic inflammation (145) and recently has been regarded as a 
predictor of cardiovascular disease.(130,149)  Many studies reported higher 
level of CRP among people exposed to passive smoking,(146-148) leading to 
accelerated atherosclerosis and subsequently increased mortality rates in the 
middle and later years of life. In this study, although the mean plasma level of 
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CRP was slightly higher in the group of cases than the group of controls, 
the difference was statistically insignificant. However, since the plasma 
concentrations of the other cytokines TNFα and IL4 were found to be 
significantly elevated, the insignificant rise in plasma CRP did not exclude 
presence of inflammatory process within the airways.  
 
 
4.5 Knowledge and attitude of parents towards passive smoking 
In this study, it was confirmed that the adverse health effects of passive 
smoking on children and adolescents were known to most parents in the 
study group, irrespective of their educational attainment. However, a 
significant difference was detected in the attitude of fathers of the two 
groups (cases and controls) towards smoking near their pregnant wives. 
This finding suggested that the knowledge about the negative effects of 
passive smoking on child’s health did not prevent fathers in the group of 
cases from smoking near their children or near their wives during 
pregnancy. Similar results were reported by Liem and his colleagues (204) 
who found that parent’s of asthmatic children do not quit smoking or stop 
smoking at home in the presence of an asthmatic child. Moreover, many 
randomized controlled trials with interventions to ban parental smoking at 
home found that parents are unlikely to change their behavior.(205-208)  
 
 
4.6 Effect of passive smoking on child’s health 
Children exposed to environmental tobacco smoke at home, compared to 
those who are not exposed, have higher frequency of hospital admissions 
due to repeated illnesses (63) and higher incidence of influenza, pneumonia 
and bronchitis.(64-65) In addition, middle ear problems that need surgical 
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treatment are more likely to occur in children who live in households where 
more than three packs of cigarettes are smoked per day.(70)  
 
In this study, no significant difference in the frequency of hospital 
admission between children in the group of cases and those in the group of 
controls was detected. In addition, no significant difference was found in 
the frequency of upper respiratory tract infection, pneumonia, otitis media 
or surgical interventions between the two groups. Further cross sectional 
studies with larger sample sizes may be needed to test the effect of passive 
smoking on child’s health.  
 
 
4.7 Effect of passive smoking on sleep 
Habitual snoring during sleep is a well known complication of smoking in 
both children and adults. Many studies described smoking-snoring 
association in passive smokers as well as active smokers.(209-212) The 
association was found to be independent of both obesity and sex.(213) In 
this study, a significant relation was found between passive smoking and 
snoring during sleep. The percentage of pupils who were suffering from 
snoring was significantly higher in the group of cases than in the group of 
controls. However, the exact mechanism by which tobacco smoke induces 
snoring is unknown. Smoking-induced inflammatory damage to mucosal 
neural mechanisms that are supposed to act against snoring is a 
possibility.(213) However, the current medical research is expected to 
clarify this area in the future. 
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4.8 Effect of passive smoking on academic performance 
The negative effects of passive smoking on cognitive function and mental 
development are well known late complications in adults. Passive smoking 
has also been associated with learning difficulties, behavior problems, and 
language difficulties in childhood;(214) however, further work is needed to 
clarify the exact mechanism of this association. In this study, the 
percentage of pupils with excellent academic performance in the last school 
examination was higher among controls than cases whereas the percentage 
of those with weak academic performance was higher among cases than 
controls. These findings were not different from findings in many other 
studies worldwide. For example, Yolton et al. found deficits in reading and 
reasoning skills among children even at low levels of tobacco smoke 
exposure.(85)  
 
 
In this study, effects of passive smoking on spirometric values and plasma 
level of inflammatory markers were tested among healthy pupils of 
“governmental schools” for boys; however, the effects on girls are not 
studied. On the other hand, the effects of passive smoking on pupils of 
“private schools” need to be documented because the difference in 
socioeconomic status of pupils in the two types of school may influence the 
mean values of the results. Previous studies showed that high 
socioeconomic factors operating from early life, including the overall 
household income, affect the adult FEV1 and the risk of developing COPD 
independently of smoking in both males and females.(215) On the other 
hand, low socioeconomic status has recently been related to higher levels 
of inflammatory markers.(216,217) Further research is needed to quantify 
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the influence of socioeconomic factors on lung function and inflammatory 
markers in both males and females. 
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CONCLUSION 
1- Passive smoking can initiate inflammatory reaction and elevate the 
plasma level of the inflammatory markers IL4 and TNF.  The response 
is accelerated when the dose of passive smoking is high. 
2- Passive smoking has a significant negative impact on lung function of 
healthy school pupils in Khartoum. It causes 7-8% reduction in the 
spirometric parameters FVC and FEV1. 
3- Most parents of school pupils in Khartoum have knowledge about the 
adverse effects of passive smoking on child’s health. 
4- Knowledge about the negative effects of passive smoking on child’s 
health does not prevent fathers from smoking near their children or near 
their wives during pregnancy. 
5- Passive smoking is not associated with higher frequency of hospital 
admission among school pupils in Khartoum. 
6- Passive smoking is not associated with higher incidence of upper 
respiratory tract infection, pneumonia, otitis media or surgical 
interventions among school pupils in Khartoum. 
7- Passive smoking in school-pupils has a significant relation to snoring 
during sleep. 
8- Passive smoking in school pupils is associated with weaker academic 
performance. 
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RECOMMENDATIONS 
1- Educational programs are highly recommended to increase awareness of 
parents about the negative impact of passive smoking on child’s health 
in order to decrease second-hand smoke indoors. 
2- Public health policies are needed to protect children from cigarette 
smoke of their parents. 
3- Further scientific research should be promoted to investigate other risks 
associated with passive smoking. 
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